IOL Chemicals and Pharmaceuticals Limited

NSE:IOLCP.NS

398.15 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 21,327.922,171.121,683.719,461.418,635.116,550.29,621.47,106.5315,804.1533,847.2535,635.0134,815.114,706.8263,894.0743,494.2033,018.5853,179.4292,025.94
Cost of Revenue 16,608.815,470.915,966.611,241.710,846.510,669.57,115.24,908.4374,136.0442,792.2793,699.252,999.782,999.5212,833.5132,816.6282,477.5462,576.6031,715.949
Gross Profit 4,719.16,700.25,717.18,219.77,788.65,880.72,506.22,198.0941,668.1091,054.9741,935.7631,815.331,707.3051,060.561677.575541.039602.826309.992
Gross Profit Ratio 0.2210.3020.2640.4220.4180.3550.260.3090.2870.2740.3440.3770.3630.2720.1940.1790.190.153
Reseach & Development Expenses 151.6167.5111.474.767.658.732.929.610.90314.11100000000
General & Administrative Expenses 66.958.34540.524.414.610.19.3077.13248.1890.5410.447045.40138.79836.12728.30320.649
Selling & Marketing Expenses 512.5618.5668.4507.8484.5466.1258.1000.006112.69233.5930174.522140.90996.693124.43460.313
SG&A 3,042.3676.8713.4548.3508.9480.7268.29.3077.13248.195398.305234.040219.923179.707132.82152.73780.962
Other Expenses 300.7256.133.112.714.87.41,294.80.180.180.180.180.181,237.343382.241202.655148.047128.57166.397
Operating Expenses 3,042.34,905.13,555.22,688.32,406.32,107.81,5631,477.6651,450.4781,231.1511,294.4611,238.481,237.343602.164382.362280.866308.561156.469
Operating Income 1,676.81,8012,161.25,530.75,381.63,772.2908.554.774-385.502-754.3850.82329.584469.961458.397295.213260.172294.265153.523
Operating Income Ratio 0.0790.0810.10.2840.2890.2280.0940.008-0.066-0.1960.0090.0060.10.1180.0840.0860.0930.076
Total Other Income Expenses Net 139.785.587.3183.2-49.2-410.7-595.5-665.655-603.134-578.203-590.478-547.266-431.985-367.965-148.674-149.195-130.598-66.53
Income Before Tax 1,816.51,886.52,248.55,713.95,332.43,361.531354.774-385.502-754.3850.82329.58437.97790.431146.54110.977163.66786.993
Income Before Tax Ratio 0.0850.0850.1040.2940.2860.2030.0330.008-0.066-0.1960.0090.0060.0080.0230.0420.0370.0510.043
Income Tax Expense 472.2495.1571.81,268.31,719.5994.53612.49914.756-87.87317.82913.698-9.55628.63946.38-15.96540.03311.485
Net Income 1,344.31,391.41,676.74,445.63,612.92,36727742.275-400.258-666.50732.99415.88647.53361.792100.16126.943123.63375.508
Net Income Ratio 0.0630.0630.0770.2280.1940.1430.0290.006-0.069-0.1730.0060.0030.010.0160.0290.0420.0390.037
EPS 22.923.728.5676.2163.5142.114.930.83-7.6-16.721.210.611.852.524.698.1810.269.18
EPS Diluted 22.923.728.5676.2163.3842.114.930.83-7.6-16.631.210.611.832.524.687.877.69.18
EBITDA 2,305.92,512.82,855.46,113.45,849.94,152.71,210.6860.526366.35875.45957.395890.591709.322696.025395.325360.189367.54188.35
EBITDA Ratio 0.1080.1130.1320.3140.3140.2510.1260.1210.0630.020.170.1850.1510.1790.1130.1190.1160.093